Malaysia has entered the recovery phase of control movement order (RCMO) starting from 10th June 2020 till 31st August 2020 hoping to further bring down the infection figure. At the current stage, many restrictions have been loosened by the government to boost economic growth. In echo to the RCMO, UMMC […]

Greeting from Clinical Investigation Centre (CIC), We would like to take this opportunity to thank you for your kind support to CIC all this while. Wishing everyone 'Selamat Hari Raya Aidilfitri & Maaf Zahir Batin! and Happy Holiday!'

Factsheet written by Dr Phan Chia Wei, Head of CIC, on clinical trials on COVID-19 worldwide. The factsheet is published by the Academy of Science Malaysia (ASM) in collaboration with the Young Scientists Network (YSN). To add, we would like to express our heartiest congratulations to a new clinical trial […]

Ahlan Wa Sahlan Ya Ramadhan. Wishing everyone a Blessed Ramadhan Kareem. More

Malaysia is embarking on a clinical study to evaluate the drug Tocilizumab for the treatment of severe cases of Covid-19. Led by Universiti Malaya Faculty of Medicine dean Professor Datuk Dr Adeeba Kamarulzaman, the trial is underway at Universiti Malaya Medical Centre (UMMC), together with three public hospitals: Sungai Buloh […]

Great news and new hope! CIC and the UMMC Covid-19 special taskforce go full force looking for new treatment for Covid-19 patients. “UMMC has already used tocilizumab (trade name Actemra) on several Covid-19 patients who developed “cytokine storm” syndrome, a dangerous overreaction of the immune system, resulting in respiratory and […]